S 10466 NY
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
This New York bill modifies prescription label requirements for certain medications including gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, and hormone replacement therapy drugs. The bill allows prescription labels for these medications to include the name of the dispensing practice instead of the name of the individual prescriber. The bill also provides for notice to patients regarding this change.
AI-generated plain-language summary of the bill (from the OpenStates abstract — no full text available yet) — neutral, and may be imperfect.
Official abstract
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
Sponsor (1)
- Erik Bottcher Democratic · primary
Action history (1)
- May 15, 2026 REFERRED TO HIGHER EDUCATION · upper
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments